ym 09151-2 has been researched along with haloperidol in 26 studies
| Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
|---|---|---|---|---|---|
| 249 | 6 | 13 | 20,330 | 1,753 | 3,294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (26.92) | 18.7374 |
| 1990's | 9 (34.62) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dragunow, M; Faull, RL; Jansen, K; Robertson, GS; Robertson, HA | 1 |
| Kobayashi, T; Shimizu, H; Toru, M | 1 |
| Arai, I; Higuchi, T; Kazawa, T; Mikuni, M; Takahashi, K; Yamauchi, T | 1 |
| Chihara, K; Fujita, T; Kaji, H; Kita, T; Kodama, H; Minamitani, N | 1 |
| Wambebe, C | 1 |
| Fitten, J; Gordon, LI; Kodama, CK; Menon, MK | 1 |
| Jenks, BG; Tonon, MC; Vaudry, H; Verburg-Van Kemenade, BM | 1 |
| Maeno, H; Nishikori, K; Noshiro, O; Usuda, S | 1 |
| Daus, FJ; Hansen, HA; Plantjé, JF; Stoof, JC | 1 |
| Costall, B; Naylor, RJ; Tan, CC | 1 |
| Kido, H; Mori, H; Sakamoto, H; Shiba, K; Sumiyoshi, T; Suzuki, K; Urasaki, K; Yamaguchi, N; Yokogawa, K | 1 |
| Asghari, V; Buchwaldt, S; Jovanovic, V; Paterson, A; Sanyal, S; Van Tol, HH | 1 |
| Creese, I; Florijn, WJ; Tarazi, FI | 1 |
| Hidaka, K; Koshiya, K; Kurokawa, K; Narita, M; Ohmori, J; Satoh, K | 1 |
| Fang, H; Helmeste, DM; Li, M; Tang, SW | 1 |
| Kleven, MS; Koek, W; Prinssen, EP | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Nagashima, U; Ono, S; Otani, K; Suzuki, A | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Ono, S; Otani, K; Suzuki, A; Yasui, N | 1 |
| Furukori, H; Inoue, Y; Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Suzuki, A; Yasui-Furukori, N | 1 |
| Copolov, DL; Dean, B; Hussain, T; Pavey, G; Scarr, E | 1 |
| Ishiwata, K; Kawamura, K; Kobayashi, T; Matsuno, K | 1 |
| Cho, H; Cho, YS; Choi, KI; Jeong, D; Jung, JY; Jung, SH; Kim, GD; Koh, HY; Kong, JY; Lee, S; Pae, AN; Park, WK; Yun, CW | 1 |
| Assié, MB; Auclair, A; Bardin, L; Consul-Denjean, N; Depoortère, R; Newman-Tancredi, A; Sautel, F | 1 |
| Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
| Becú-Villalobos, D; Bello, EP; Casas Cordero, R; Gelman, DM; Low, MJ; Luque, GM; Noaín, D; Peper, M; Pérez-Millán, MI; Rubinstein, M; Tornadu, IG | 1 |
| Dold, M; Kasper, S; Leucht, S; Li, C; Samara, MT; Tardy, M | 1 |
1 review(s) available for ym 09151-2 and haloperidol
| Article | Year |
|---|---|
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials.
Topics: Antipsychotic Agents; Benzamides; Haloperidol; Humans; Publication Bias; Randomized Controlled Trials as Topic; Sample Size; Schizophrenia; Treatment Outcome | 2016 |
2 trial(s) available for ym 09151-2 and haloperidol
| Article | Year |
|---|---|
No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
Topics: Acute Disease; Alleles; Antipsychotic Agents; Benzamides; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Extrapyramidal Tracts; Female; Haloperidol; Humans; Male; Pilot Projects; Polymorphism, Restriction Fragment Length; Receptors, Dopamine D2; Reproducibility of Results; Schizophrenia | 2000 |
No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
Topics: Adult; Benzamides; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia | 2001 |
23 other study(ies) available for ym 09151-2 and haloperidol
| Article | Year |
|---|---|
D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons.
Topics: Animals; Benzamides; Benzazepines; Corpus Striatum; Dizocilpine Maleate; Dopamine Antagonists; Guanidines; Haloperidol; Male; N-Methylaspartate; Neurons; Oncogene Proteins v-fos; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid; Receptors, sigma | 1990 |
[The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzamides; Benzazepines; Chlorpromazine; Depression, Chemical; Female; Haloperidol; Humans; In Vitro Techniques; Putamen; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Sulpiride | 1990 |
Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
Topics: Animals; Benzamides; Binding Sites; Corpus Striatum; Dopamine Antagonists; Frontal Lobe; Haloperidol; In Vitro Techniques; Ketanserin; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1990 |
Effect of various catecholamine antagonists on prolactin secretion in conscious male rabbits.
Topics: Animals; Antipsychotic Agents; Benzamides; Catecholamines; Chlorpromazine; Consciousness; Haloperidol; Male; Metoprolol; Pimozide; Prazosin; Prolactin; Propranolol; Rabbits; Radioimmunoassay; Yohimbine | 1985 |
Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
Topics: Aging; Animals; Antipsychotic Agents; Benzamides; Catalepsy; Chickens; Dextroamphetamine; Fenclonine; Haloperidol; Male; Rats; Rats, Inbred Strains; Stereoisomerism; Stereotyped Behavior; Sulpiride | 1987 |
Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anti-Anxiety Agents; Apomorphine; Benzamides; Benzazepines; Dopamine; Dopamine Antagonists; Ergolines; Haloperidol; Hypothermia; Male; Mice; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1988 |
Characteristics of receptors for dopamine in the pars intermedia of the amphibian Xenopus laevis.
Topics: Animals; Apomorphine; Benzamides; Domperidone; Dopamine; Drug Interactions; Ergolines; Haloperidol; Melanocyte-Stimulating Hormones; Pituitary Gland, Anterior; Quinpirole; Receptors, Dopamine; Sulpiride; Xenopus laevis | 1986 |
Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Chlorpropamide; Dogs; Drug Evaluation, Preclinical; Female; Haloperidol; Humans; Hypothermia; Male; Methamphetamine; Mice; Mice, Inbred ICR; Receptors, Dopamine; Stereotyped Behavior; Sulpiride; Vomiting | 1981 |
The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholine; Animals; Antipsychotic Agents; Aporphines; Benzamides; Benzazepines; Caudate Nucleus; Chlorpromazine; Clozapine; Flupenthixol; Haloperidol; In Vitro Techniques; Male; Piperidines; Potassium; Putamen; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
Neuronally mediated contraction responses of guinea-pig stomach smooth muscle preparations: modification by benzamide derivatives does not reflect a dopamine antagonist action.
Topics: Animals; Benzamides; Domperidone; Electric Stimulation; Guinea Pigs; Haloperidol; In Vitro Techniques; Male; Metoclopramide; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Receptors, Dopamine; Stomach | 1984 |
In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Cerebellum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Isoxazoles; Ketanserin; Ligands; Male; Neostriatum; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone | 1994 |
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
Topics: Animals; Benzamides; Cell Line; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; Dinoprostone; Dopamine; Haloperidol; HeLa Cells; Humans; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone; Transfection | 1995 |
Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzamides; Benzazepines; Brain; Clozapine; Corpus Striatum; Haloperidol; Iodine Radioisotopes; Male; Organ Specificity; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Salicylamides; Spiperone; Tetrahydronaphthalenes; Time Factors; Tritium; Up-Regulation | 1997 |
Effects of YM-43611, a novel dopamine D2-like receptor antagonist, on immediate early gene expression in the rat forebrain.
Topics: Animals; Benzamides; Clozapine; Dopamine Antagonists; Haloperidol; Immunohistochemistry; Male; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1997 |
Multiple [3H]-nemonapride binding sites in calf brain.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Benzamides; Binding, Competitive; Brain; Cattle; Cerebellum; Cerebral Cortex; Corpus Striatum; Dioxanes; Dopamine Agonists; Dopamine Antagonists; Guanidines; Haloperidol; In Vitro Techniques; Isotope Labeling; Narcotic Antagonists; Pentazocine; Piperidines; Propylamines; Pyrrolidines; Receptors, Dopamine D2; Receptors, sigma; Sulpiride; Tritium | 1997 |
The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties.
Topics: Animals; Antipsychotic Agents; Benzamides; Catalepsy; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Male; Piperazines; Pyridines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Salicylamides; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |
The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Anxiety; Benzamides; Depression; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia | 2001 |
Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.
Topics: Animals; Antipsychotic Agents; Benzamides; Benzazepines; Benzodiazepines; Chlorpromazine; Clozapine; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Male; Muscimol; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, GABA-A | 2001 |
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands.
Topics: Animals; Benzamides; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Ligands; Male; Mice; Nootropic Agents; Piperazines; Raclopride; Receptors, Dopamine D2; Receptors, sigma | 2003 |
Pharmacological actions of a novel and selective dopamine D3 receptor antagonist, KCH-1110.
Topics: Animals; Antipsychotic Agents; Benzamides; Binding, Competitive; Body Temperature; Catalepsy; Cell Line; Clozapine; Cocaine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Hypothermia; Isoxazoles; Male; Mice; Motor Activity; Prolactin; Psychomotor Performance; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Thiophenes; Tritium | 2003 |
F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzofurans; Benzylamines; Cyclopentanes; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Mice; Receptors, Dopamine D3; Receptors, Dopamine D4; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists | 2007 |
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording | 2009 |
Central dopamine D2 receptors regulate growth-hormone-dependent body growth and pheromone signaling to conspecific males.
Topics: Analysis of Variance; Animals; Benzamides; Body Size; Body Weight; Case-Control Studies; Catatonia; Dopamine Antagonists; Eating; Female; Growth Hormone; Haloperidol; Insulin-Like Growth Factor I; Intermediate Filament Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nestin; Oligodeoxyribonucleotides, Antisense; Pheromones; Pituitary Gland; Prolactin; Protein Binding; Proteins; Radioimmunoassay; Receptors, Dopamine D2; Social Dominance; Territoriality; Tritium | 2013 |